The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. (Q36616812)
Jump to navigation
Jump to search
scientific article published on May 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. |
scientific article published on May 2005 |
Statements
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations (English)
G M Tozer
K M Brindle
J L Evelhoch
I R Judson
M V Knopp
R J Maxwell
D McIntyre
A R Padhani
P Price
R Rathbone
G J Rustin
W Vennart
J C Waterton
P Workman
Pharmacodynamic/Pharmacokinetic Technologies Advisory Committee, Drug Development Office, Cancer Research UK
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference